How does ICH E9 improve the design of Cancer Clinical Trials?
ICH E9 provides detailed recommendations on trial design aspects, such as randomization, blinding, and sample size determination. These elements are crucial for minimizing bias and ensuring that the trial results are valid. For instance, randomization helps in evenly distributing confounding factors across treatment groups, while blinding reduces the risk of biased assessments of outcomes.
